Moat Biotechnology Is BSV’s Latest Investment
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
405 Business recently named BSV Founder/Managing Partner James Spann one of “10 for the Next 10” for the Oklahoma City area.
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
This article highlights James Spann’s passion for financially supporting and guiding promising entrepreneurs.
A former Norman City Council member praised BSV for helping to complete the circle of entrepreneurial-based job creation life in the city.